Inzlingen
Germany
61
2019-08-15
The entities that hold a legal rights for patent applications filed by inventor Roever Stephan:
Stephan Roever from Inzlingen, DE has applied for patents for these inventions. The list has both pending applications and granted patents:
NOVEL PYRIDINE DERIVATIVES
#2 | 2018-11-15NOVEL PYRIDINE DERIVATIVES
#3 | 2018-11-15NOVEL PYRIDINE DERIVATIVES
#4 | 2017-02-09Pyrazol derivatives
#5 | 2016-12-29NOVEL PYRIDINE DERIVATIVES
#6 | 2016-12-29NOVEL PYRIDINE DERIVATIVES
#7 | 2016-08-044-amino-imidazoquinoline compounds
#8 | 2016-06-16Triazolo[4,5-D]pyrimidine derivatives
#9 | 2016-05-19NOVEL PYRIDINE DERIVATIVES
#10 | 2016-03-24NOVEL TETRAZOLONE DERIVATIVES
#11 | 2016-02-18Pyrrolo[2,3-D]pyrimidine derivatives as CB2 receptor agonists
#12 | 2016-02-18Purine derivatives as CB2 receptor agonists
#13 | 2015-12-03Pyridine-2-amides useful as CB2 agonists
#14 | 2015-10-29Pyridine derivatives
#15 | 2015-10-22Pyrazine derivatives as CB2 receptor agonists
#16 | 2015-10-224-amino-imidazoquinoline compounds
#17 | 2015-10-22Pyridine-2-amides useful as CB2 agonists
#18 | 2014-09-25[1,2,3]triazolo[4,5-D]pyrimidine derivatives
#19 | 2014-07-10Heteroarylmethyl amides
#20 | 2013-05-30[1,2,3]triazolo[4,5-D]pyrimidine derivatives
#21 | 2013-05-09[1,2,3]triazolo[4,5-D]pyrimidine derivatives
#22 | 2013-05-02Pyrazine derivatives
#23 | 2013-03-14N-(5-cycloalkyl)-pyridin-3-yl carboxamides
#24 | 2013-03-145-cycloalkyl- or 5-heterocyclyl-nicotinamides
#25 | 2013-03-143-pyridine carboxylic acid hydrazides
#26 | 2012-12-13Pyridine derivatives as agonists of the CB2 receptor
#27 | 2012-06-21Pyridine, pyridazine, pyrimidine or pyrazine carboxamides as HDL-cholesterol raising agents
#28 | 2012-04-19-pyridin-3-yl or -pyrazin-2-yl carboxamides
#29 | 2012-03-15Heteroarylmethyl amides
#30 | 2011-03-175-(3,4-dichloro-phenyl)--(2-hydroxy-cyclohexyl)-6-(2,2,2-trifluoro-ethoxy)-nicotinamide and salts thereof
#31 | 2010-10-21Pyrazinecarboxamide derivatives as HDL-cholesterol raising agents
#32 | 2010-03-04STEREOSPECIFICALLY SUBSTITUTED BENZO[1,3]DIOXOLYL DERIVATIVES
#33 | 2009-10-012-trifluoromethylnicotinamide derivatives as HDL-cholesterol raising agents
#34 | 2009-10-013-trifluoromethyl-pyrazine-2-carboxylic acid amide derivatives as HDL-cholesterol raising agents
#35 | 2009-06-043-pyridinecarboxamide derivatives as HDL-cholesterol raising agents
#36 | 2009-02-19Piperazine amide derivatives
#37 | 2008-10-02Imidazolidinone derivatives
#38 | 2008-09-25Indole or benzimidazole derivatives as CBinverse agonists
#39 | 2008-04-103-Pyridinecarboxamide derivatives as HDL-cholesterol raising agents
#40 | 2008-04-10Pyrazine-2-carboxamide derivatives as CB2 receptor modulators
#41 | 2008-03-205-phenyl-nicotinamide derivatives
#42 | 2007-12-20Pyrazinecarboxamide derivatives as CB1 antagonists
#43 | 2007-11-29Pyridopyrimidinone derivatives which are HM74A agonists
#44 | 2007-11-20Benzothiazolyl derivatives
#45 | 2007-11-13CB 1 receptor inverse agonists
#46 | 2007-10-11CB 1 receptor inverse agonists
#47 | 2007-05-10Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino [1,2-a] indoles
#48 | 2007-01-25Benzothiazolyl derivatives
#49 | 2006-12-28Stereospecifically substituted benzo[1,3]dioxolyl derivatives
#50 | 2006-11-09Tetracyclic 6 azapyrazinoindolines as 5HT2C receptor agonists for obesity
#51 | 2006-10-12Pyridine-3-carboxamide derivatives as CB1 inverse agonists
#52 | 2006-08-291,2,3,4,9,9a-hexahydro-2,4a,5-triaza-fluorene and 1,2,3,4-tetrahydro-2,4a,5-triaza-fluorene derivatives
#53 | 2006-08-10Morpholine derivatives as 5HT2C receptor agonists for the treatment of obesity
#54 | 2006-04-27Indole or benzimidazole derivatives as CB1 inverse agonists
#55 | 2006-04-04Piperazine derivatives
#56 | 2005-11-10Heterocyclic cannabinoid receptor antagonists
#57 | 2005-10-27Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino[1,2-a]indoles
#58 | 2005-08-23Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino[1,2-a]indoles
#59 | 2005-07-14Thiazole derivatives
#60 | 2005-02-035HT2c receptor agonists
#61 | 2005-01-18Piperazine derivatives
140974 ⎘